FOXP3+ T regulatory cells in idiopathic inflammatory myopathies

Waschbisch A, Schwab N, Ruck T +2 more2010Journal of NeuroimmunologyJournal Article

10.1016/j.jneuroim.2010.03.013 PubMed

Immune/InnateMusculoskeletal

Abstract

FOXP3+ T regulatory cells (Tregs) are considered key players in the maintenance of immune homeostasis. Here we studied the presence and potential role of FOXP3+ Tregs in myositis. CD3 and FOXP3 expression in dermatomyositis, polymyositis and inclusion body myositis was assessed by immunohistochemistry and real-time PCR. FOXP3+ Tregs were found in close proximity to effector cells and their numbers correlated with the degree of inflammation. Despite divergent pathogenetic concepts, we observed no differences in the frequency of FOXP3 immunoreactive cells or FOXP3 mRNA expression between different myositis entities. Functional assays using human myoblasts as targets of CD8+ cells demonstrate that Tregs are capable to inhibit the lytic activity of cytotoxic cells. Our data suggest that FOXP3 Tregs serve to counterbalance muscle destruction by cytotoxic T cells in myositis.

Key Biomarkers

CD3Foxp3 mRNAFOXP3+ T regulatory cells

Symptom Clusters

DermatomyositisInclusion body myositisMyositisPolymyositis

References (1)

The role of regulatory T cells in multiple sclerosisNature Clinical Practice Neurology · 2008